文献速递血栓与止血

编码糖蛋白Ibβ的基因半合子状态并非22q11缺失综合征患者巨血小板减少症和出血的原因

Hemizygosity for the gene encoding glycoprotein Ibβ is not responsible for macrothrombocytopenia and bleeding in patients with 22q11 deletion syndrome.
PubMed 文献 · J Thromb Haemost · 2019-01-22

本研究对22q11缺失综合征(22q11DS)患者的出血严重程度、平均血小板体积、血小板计数及GPIBB拷贝数和序列进行了全面分析,发现巨血小板减少症和轻度出血见于不完全重叠的患者亚群,且GPIBB拷贝数和序列变异与巨血小板减少症或出血均不相关,表明GPIBB半合子状态不导致这些表现。

要点

  • 22q11DS患者中巨血小板减少症与轻度出血见于不完全重叠的亚群。
  • GPIBB拷贝数和序列变异与巨血小板减少症或出血无相关性。
  • GPIBB半合子状态不导致22q11DS患者的巨血小板减少症或出血。

核心结论

  • GPIBB半合子状态不导致22q11DS患者的巨血小板减少症或出血。

研究设计与样本

  • 对22q11DS患者进行出血严重程度、平均血小板体积、血小板计数及GPIBB拷贝数和序列的全面特征分析。

主要发现

  • 巨血小板减少症和轻度出血见于不完全重叠的22q11DS患者亚群。
  • GPIBB拷贝数和序列变异与巨血小板减少症或出血均不相关。

临床怎么用

  • 作者讨论了其他导致巨血小板减少症的遗传原因、获得性血小板减少和出血的可能原因,以及如何利用血小板大小、血小板计数和GPIBB序列信息辅助22q11DS患者的诊断和管理。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Essentials How thrombocytopenia relates to bleeding in 22q11 deletion syndrome (22q11DS) is not clear. Bleeding severity, platelet count and volume, and GPIBB were examined in patients with 22q11DS. Macrothrombocytopenia and bleeding typified imperfectly overlapping subsets of 22q11DS patients. GPIBB hemizygosity does not cause macrothrombocytopenia or bleeding in patients with 22q11DS. SUMMARY: Background and objectives Macrothrombocytopenia and bleeding are frequently associated with 22q11 deletion syndrome (22q11DS). GPIBB, which encodes the glycoprotein (GP) Ibβ subunit of GPIb-IX-V, is commonly deleted in patients with 22q11DS. Absence of functional GPIb-IX-V causes Bernard-Soulier syndrome, which is a severe bleeding disorder characterized by macrothrombocytopenia. Patients with 22q11DS are often obligate hemizygotes for GPIBB, and those with only a pathogenically disrupted copy of GPIBB present with Bernard-Soulier syndrome. The objective of this study was to determine how GPIBB hemizygosity and sequence variation relate to macrothrombocytopenia and bleeding in patients with 22q11DS who do not have Bernard-Soulier syndrome. Patients/methods We thoroughly characterized bleeding severity, mean platelet volume, platelet count and GPIBB copy number and sequence in patients with 22q11DS. Results and conclusions Macrothrombocytopenia and mild bleeding were observed in incompletely overlapping subsets of patients, and GPIBB copy number and sequence variation did not correlate with either macrothrombocytopenia or bleeding in patients with 22q11DS. These findings indicate that GPIBB hemizygosity does not result in either macrothrombocytopenia or bleeding in these patients. Alternative genetic causes of macrothrombocytopenia, potential causes of acquired thrombocytopenia and bleeding and ways in which platelet size, platelet count and GPIBB sequence information can be used to aid in the diagnosis and management of patients with 22q11DS are discussed.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Zwifelhofer NMJ, Bercovitz RS, Weik LA, et al. Hemizygosity for the gene encoding glycoprotein Ibβ is not responsible for macrothrombocytopenia and bleeding in patients with 22q11 deletion syndrome. J Thromb Haemost. 2019. PMID: 30549403. doi:10.1111/jth.14357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。